Epilepsy, Complex Partial
13
0
0
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.7%
1 terminated out of 13 trials
92.3%
+5.8% vs benchmark
69%
9 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (13)
Neural Correlates of Cognition and Mood
A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601
Bioavailability, Safety, and Tolerability of BIS-001 ER
Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin
Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.
An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.
An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy
Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism
Pregabalin Open-Label Extension Trial in Patients With Partial Seizures